Lundbeck Ready To Funnel 2022 Growth Into Expected Alzheimer’s Agitation Launch

 
• By Joseph Haas

The Danish firm’s four key products yielded 31% sales growth in 2022, and the company is investing in the anticipated mid-year launch of an Alzheimer’s agitation indication for Rexulti.

Lundbeck
Lundbeck is getting for an approval in Alzheimer's agitation • Source: Shutterstock

More from Earnings

More from Business